Managing paraneoplastic GABABR-related limbic encephalitis in a patient with a small cell lung cancer receiving an Immune-Checkpoint Inhibitor (ICI) therapy: description of a case report

Abstract Introduction GABAB receptor (GABABR)-related paraneoplastic limbic encephalitis (PLE) is frequently associated with cancer, particularly small cell lung carcinoma (SCLC) and shows several clinical presentations often accompanied by distinctive MRI and EEG findings. It can be exacerbated by...

詳細記述

書誌詳細

主要な著者:	Mathilde Cezar, Rachele Belletto, Sara Polidori, Lisa Soive, Marco Campitiello, Pierre-Olivier Legros, Julie Egea, Francesca Plastino, Marie Benaiteau, Louise Tyvaert, Giampaolo Tortora, Raffaele Longo
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2025-11-01
シリーズ:	BMC Neurology
主題:	Limbic encephalitis SCLC GABAB receptor Atezolizumab Case report
オンライン･アクセス:	https://doi.org/10.1186/s12883-025-04483-z
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!